149 related articles for article (PubMed ID: 25001177)
1. Netrin-1 promoted pancreatic cancer cell proliferation by upregulation of Mdm2.
Huang Q; Hua HW; Jiang F; Liu DH; Ding G
Tumour Biol; 2014 Oct; 35(10):9927-34. PubMed ID: 25001177
[TBL] [Abstract][Full Text] [Related]
2. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
5. [The role of Gli1 in the invasion and migration of pancreatic cancer cells].
Sheng W; Dong M; Zhou J; Liu Q; Li X; Dong Q
Zhonghua Wai Ke Za Zhi; 2014 Jul; 52(7):518-22. PubMed ID: 25262609
[TBL] [Abstract][Full Text] [Related]
6. PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.
Zhan B; Kong C; Guo K; Zhang Z
Tumour Biol; 2013 Jun; 34(3):1759-66. PubMed ID: 23526078
[TBL] [Abstract][Full Text] [Related]
7. Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death.
Paradisi A; Creveaux M; Gibert B; Devailly G; Redoulez E; Neves D; Cleyssac E; Treilleux I; Klein C; Niederfellner G; Cassier PA; Bernet A; Mehlen P
EMBO Mol Med; 2013 Dec; 5(12):1821-34. PubMed ID: 24293316
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
9. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
Li Y; Xiao M; Guo F
Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar localization of a netrin-1 isoform enhances tumor cell proliferation.
Delloye-Bourgeois C; Goldschneider D; Paradisi A; Therizols G; Belin S; Hacot S; Rosa-Calatrava M; Scoazec JY; Diaz JJ; Bernet A; Mehlen P
Sci Signal; 2012 Aug; 5(236):ra57. PubMed ID: 22871610
[TBL] [Abstract][Full Text] [Related]
11. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
[TBL] [Abstract][Full Text] [Related]
12. Functional implication of Netrin expression in malignant melanoma.
Kaufmann S; Kuphal S; Schubert T; Bosserhoff AK
Cell Oncol; 2009; 31(6):415-22. PubMed ID: 19940358
[TBL] [Abstract][Full Text] [Related]
13. Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness.
Yan W; Han P; Zhou Z; Tu W; Liao J; Li P; Liu M; Tian D; Fu Y
Dig Dis Sci; 2014 Jun; 59(6):1213-21. PubMed ID: 24442237
[TBL] [Abstract][Full Text] [Related]
14. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.
Fitamant J; Guenebeaud C; Coissieux MM; Guix C; Treilleux I; Scoazec JY; Bachelot T; Bernet A; Mehlen P
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4850-5. PubMed ID: 18353983
[TBL] [Abstract][Full Text] [Related]
15. Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor.
Wang W; Reeves WB; Ramesh G
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F723-9. PubMed ID: 19211685
[TBL] [Abstract][Full Text] [Related]
16. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
17. Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors.
Yang YH; Szabat M; Bragagnini C; Kott K; Helgason CD; Hoffman BG; Johnson JD
Diabetologia; 2011 Apr; 54(4):828-42. PubMed ID: 21212933
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
20. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function.
Azmi AS; Aboukameel A; Banerjee S; Wang Z; Mohammad M; Wu J; Wang S; Yang D; Philip PA; Sarkar FH; Mohammad RM
Eur J Cancer; 2010 Apr; 46(6):1122-31. PubMed ID: 20156675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
